8-K
Current Report
Xilio Therapeutics, Inc. Filed Acc 0001558370-23-005393
Executive or director change · Bylaws or fiscal year change
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading xlo-20230328x8k.htm…